Delivery Order SPE2DB22D3016-SPE2DB25FAZH8

Award Date 6/13/25
Potential Completion Date 7/8/25
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tagrisso 80 mg tablets. The contract has a ceiling value of $21,325.14 and is a firm fixed-price delivery order with a performance period through May 14, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tagrisso 40 mg tablets. The $21,016.64 firm fixed-price contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a comprehensive range of medical...
This is a $21,325.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a prescription medication, with a period of performance through July 3, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm fixed-price contract is for the delivery of the prescription medication Tagrisso 80 mg tablets. The contract has an ultimate completion date of May 12, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $21,077.60 firm fixed price contract is for the supply of Tagrisso 80 mg tablets, a specialty oncology medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the major pharmaceutical distributor AmerisourceBergen Drug Corporation. The contract is for the supply of Tagrisso 80 mg tablets, a specialty cancer medication, valued at $21,077.60. The contract has an ultimate completion date of August 13, 2024. AmerisourceBergen, a leading provider of pharmaceutical and medical supplies to the U.S. government, has been awarded numerous indefinite delivery...
This is a $21,077.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of the oncology medication TAGRISSO 80 MG TABLET 30S, with a performance period through August 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty drugs, brand-name...
This federal contract award, valued at $42,460.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply the drug Tagrisso 80 mg Tablet 30s, a medication used in cancer treatment. The contract is a firm fixed-price, non-set-aside award with a completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $21,325.14 contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a specialty medication, with a period of performance through February 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, to provide a broad range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Tagrisso 40 mg tablet 30s. The contract has a ceiling value of $10,508.31 and a period of performance through April 18, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, which serves as the prime...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAZH8
    Delivery Order

This is a $42,607.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tagrisso 80 mg tablets, a cancer medication, with a period of performance through July 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and government healthcare programs through December 2026. This delivery order is not set aside and represents open competition for the required pharmaceutical product.

Generated 9/12/25, 10:49 AM